Crossmark

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-019-5291-3

Published Online: 2019-01-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Evelönn, Emma Andersson

Landfors, Mattias

Haider, Zahra

Köhn, Linda

Ljungberg, Börje

Roos, Göran

Degerman, Sofie http://orcid.org/0000-0002-2783-0712
Funding

Funding for this research was provided by:

Medicinska fakulteten, Umeå Universitet

Lion's Cancer Research Foundation, Umeå (LPK)

Kempestiftelserna (nr)

Cancerfonden

Västerbotten Läns Landsting (nr)

Uppsala-Umeå Comprehensive Cancer Consortium (nr)
License Information

Text and Data Mining valid from 2019-01-14
More Information

Article History

Received: 25 September 2018

Accepted: 7 January 2019

First Online: 14 January 2019

Ethics approval and consent to participate

: All patients have given informed and written consent, and the study was approved by the regional ethical review board in Umeå (Dnr 2011–156-31 M, 20110523).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.